Clinica Baviera (CBAV) — Strategic Asset Allocation Index
Clinica Baviera (CBAV) has a Strategic Asset Allocation Index of 113.5% as of September 2023. Strategic assets (PP&E of €92.73 Million plus long-term investments of €-) total €92.73 Million, measured against net assets of €81.72 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See CBAV equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Clinica Baviera Strategic Asset Allocation Index (2005–2022)
This chart shows how Clinica Baviera's Strategic Asset Allocation Index has evolved across 18 annual periods from 2005 to 2022. As of September 2023, the index stands at 113.5%, representing strategic assets of €92.73 Million against net assets of €81.72 Million EUR. For live market cap and overall valuation, see Clinica Baviera market capitalisation.
Annual Strategic Asset Allocation Index for Clinica Baviera (2005–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Clinica Baviera from 2005 to 2022, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See CBAV net asset value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 125.9% | €86.08 Million | €86.08 Million | €- | €68.37 Million | ▼ -13.6 pp |
| 2021 | 139.5% | €77.25 Million | €77.25 Million | €- | €55.39 Million | ▼ -19.5 pp |
| 2020 | 159.0% | €71.40 Million | €71.40 Million | €- | €44.90 Million | ▼ -77.9 pp |
| 2019 | 236.9% | €72.98 Million | €72.94 Million | €44.00K | €30.80 Million | ▲ +141.4 pp |
| 2018 | 95.5% | €27.48 Million | €27.48 Million | €- | €28.76 Million | ▲ +3.1 pp |
| 2017 | 92.5% | €23.00 Million | €23.00 Million | €- | €24.88 Million | ▼ -5.4 pp |
| 2016 | 97.8% | €18.18 Million | €18.18 Million | €- | €18.57 Million | ▲ +20.5 pp |
| 2015 | 77.3% | €16.48 Million | €16.48 Million | €- | €21.31 Million | ▼ -8.2 pp |
| 2014 | 85.5% | €17.27 Million | €17.27 Million | €- | €20.20 Million | ▲ +19.8 pp |
| 2013 | 65.7% | €16.65 Million | €16.65 Million | €- | €25.35 Million | ▼ -35.7 pp |
| 2012 | 101.4% | €21.14 Million | €21.14 Million | €- | €20.86 Million | ▲ +11.6 pp |
| 2011 | 89.8% | €21.40 Million | €21.40 Million | €- | €23.83 Million | ▼ -1.2 pp |
| 2010 | 91.0% | €20.39 Million | €20.39 Million | €- | €22.40 Million | ▼ -13.5 pp |
| 2009 | 104.4% | €21.79 Million | €21.79 Million | €- | €20.87 Million | ▼ -35.8 pp |
| 2008 | 140.2% | €26.68 Million | €26.68 Million | €- | €19.02 Million | ▲ +34.7 pp |
| 2007 | 105.6% | €20.98 Million | €20.98 Million | €- | €19.88 Million | ▲ +41.2 pp |
| 2006 | 64.4% | €12.54 Million | €12.54 Million | €- | €19.49 Million | ▲ +5.2 pp |
| 2005 | 59.2% | €8.49 Million | €8.49 Million | €- | €14.34 Million | — |